×







We sell 100% Genuine & New Books only!

Treatment of Inflammatory Bowel Disease with Biologics 1st Editon 2018 Softbound at Meripustak

Treatment of Inflammatory Bowel Disease with Biologics 1st Editon 2018 Softbound by Adam S. Cheifetz, Joseph D. Feuerstein, Springer

Books from same Author: Adam S. Cheifetz, Joseph D. Feuerstein

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Price: ₹ 9492.00/- [ 15.00% off ]

    Seller Price: ₹ 8068.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)Adam S. Cheifetz, Joseph D. Feuerstein
    PublisherSpringer
    Edition1st Edition
    ISBN9783319868233
    Pages335
    BindingSoftbound
    LanguageEnglish
    Publish YearSeptember 2018

    Description

    Springer Treatment of Inflammatory Bowel Disease with Biologics 1st Editon 2018 Softbound by Adam S. Cheifetz, Joseph D. Feuerstein

    This book is a concise yet comprehensive overview of the use of biologics for the treatment of Crohn’s disease and ulcerative colitis. The volume details how best to utilize these medications in order to optimize their efficacy and safety, as well as how to understand, recognize, and treat complications that may arise from using biologics to treat IBD. The text also focuses on new data, novel biologics, and biosimilars of this rapidly expanding field. Written by experts in the field, Treatment of Inflammatory Bowel Disease with Biologics is a valuable resource for gastroenterologists, allied health professionals, fellows, and trainees who treat patients with inflammatory bowel disease. Mechanism of Action and Pharmacokinetics of Biologics.- Anti-tumor Necrosis Factor Agents in Ulcerative Colitis.- Anti-tumor Necrosis Factor Agents in Crohn’s Disease.- Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease.- Use of Biologics in the Postoperative Management of Crohn’s Disease.- Biologics in Pregnancy and Breastfeeding.- Concomitant Use of Immunosuppressive Therapy with Tumor Necrosis Factor (TNF) Antagonists in Inflammatory Bowel Disease.- Therapeutic Drug Monitoring of Biologic Agents.- Use of Biologics in Crohn’s Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks.- Cessation of Biologics – Can it be Done?.- Biologic Therapy in Pediatric Inflammatory Bowel Disease.- Infectious Complications of Biologics.- Tumor Necrosis Factor-Alpha Inhibitors and Risks of Malignancy.- Non-infectious and Non-malignant Complications of Biologics.- Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, State of the Finances.- Anti-Integrin Agents in IBD: Efficacy and Risk of Complications.- Novel Agents in Inflammatory Bowel Disease.- Quality, Safety, and Practical Considerations of Using Biologic Therapies. 



    Book Successfully Added To Your Cart